Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
3
result was found. Results that relate to
Sorafenib
A case of toxic epidermal necrolysis caused by sorafenib and sintilimab
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(2):224-229.
1148 times
552 times
DENG Lin
REN Chao
SUN Tao
LI Xi
GUO Shun
ZHOU Ang
Sorafenib
Sintilimab
Toxic epidermal necrolysis
Adverse drug reactions
Details
Cost-utility analysis of tislelizumab versus sorafenib as first-line treatment for advanced unresectable hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(1):109-116.
997 times
439 times
SU Zhan
CHE Jinhui
PEI Ruifeng
Hepatocellular carcinoma
Tislelizumab
Sorafenib
Partition survival model
Pharmacoeconomic analysis
Details
Efficacy and safety of tislelizumab combined with sorafenib in the treatment for unresectable hepatocellular carcinoma
Published on
Frontiers in Pharmaceutical Sciences
2024,27(8):1136-1342.
1057 times
223 times
JIANG Jinghua
HU Yiting
Tirilizumab
Sorafenib
Unresectable
Hepatocellular carcinoma
Objective response rate
Disease control rate
Progression-free survival
Overall survival
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University